Soluble Nef antigen of HIV-1 is cytotoxic for human CD4+ T cells

FEBS Letters

Volumn 393, Issue 1, 1996, Pages 93-96

  Fujii, Yoichi ^a   Otake, Kaori ^a   Tashiro, Masato ^b   Adachi, Akio ^c  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

AIDS; CD4+ T cell; Cytotoxicity; HIV 1; Nef

Indexed keywords

CD4 ANTIGEN; HYBRID PROTEIN; NEF PROTEIN;

ANTIGEN EXPRESSION; ARTICLE; BACULOVIRUS; BLOOD ANALYSIS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS INFECTION;

EID: 0030576919     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-5793(96)00859-9     Document Type: Article

References (20)

1. [1] Subbramanian, R.A. and Cohen, E.A. (1994) J. Virol. 68, 6831-6835.
2. [2] Barré-Sinoussi, F., Cherman, J.C., Rey, R., Nugeyre, M.T., Chamaret, S., Gruest, J., Dauget, C., Axler-Blin, C., Vezinet-Brun, F., Rouzioux, C., Rosenbaum, W. and Montagnier, L. (1983) Science 220, 868-871.
3. [3] Gallo, R.C., Salahuddin, S.Z., Popovic, M., Shearer, G.M., Kaplan, M., Haynes, B.F., Palker, T.J., Redfield, R., Oleske, J., Safai, B., White, G., Foster, P. and Markham, P.D. (1984) Science 224, 500-503.
4. [4] Levy, J.A., Hoffman, A.D., Kramer, S.M., Landis, J.A., Shimabukuro, J.M. and Oskiro, L.S. (1984) Science 225, 840-842.
5. [5] Ratner, L., Haseltine, W., Patarca, R., Livak, K.J., Starcich, B., Josephs, S.F., Doran, E.R., Rafalski, J.A., Whitehorn, E.A., Baumeister, K., Ivanoft, L., Petteway, S.R., Jr, Pearson, M.L., Lautenberger, J.A., Papas, T.S., Ghrayeb, J., Chang, N.T., Gallo, R.C. and Wong-Staal, F. (1985) Nature 313, 277-284.
6. [6] Sanchez-Pescador, R., Power, M.D., Barr, P.J., Steimer, K.S., Stempien, M.M., Brown-Shimer, S.L, Gee, W.W., Renard, A., Randolph, A., Levy, J.A., Dina, D. and Luciw, P.A. (1985) Science 227, 484-492.
7. [7] Wain-Hobson, S., Sonigo, P., Danos, O., Cole, S. and Alizon, M. (1985) Cell 40, 9-17.
8. [8] Cullen, B.R. (1994) Virology 205, 1-6.
9. [9] Jamieson, B.D., Aldrovandi, G.M., Planelles, V., Jowett, J.B.M., Gao, L., Bloch, L.M., Chen, I.S.Y. and Zack, J.A. (1994) J. Virol. 68, 3478-3485.
10. [10] KLestler III, H.W., Ringler, D.J., Mori, K., Panicali, D.L., Sehgal, P.K., Dniel, M.D. and Desrosiers, R.C. (1991) Cell 65, 651-662.
11. [11] Harper, M.E., Marselle, L.M., Gallo, R.C. and Wong-Staal, F. (1986) Proc. Natl. Acad. Sci. USA 83, 772-776.
12. [12] Schnittman, S.M., Psallidopoulos, M.C., Lane, H.C., Thompson, L., Baseler, M., Massari, F., Fox, C.H., Salzman, N.P. and Fauci, A.S. (1989) Science 245, 305-308.
13. [13] Embretson, J., Zupancic, M., Ribas, J.L., Burke, A., Racz, P., Tenner-Racz, K. and Haase, A.T. (1993) Nature 362, 359-362.
14. [14] Ho, D.D., Neumann, A.U., Perelson, A.S., Chen, W., Leonard, J.M. and Markowitz, M. (1995) Nature 373, 123-126.
15. [15] Baur, A.S., Sawai, E.T., Dazin, P., Fantl, W.J., Cheng-Mayer, C. and Peterlin, B.M. (1994) Immunity 1, 373-384.
16. [16] Fujii, Y., Ito, M. and Ikuta, K. (1993) Vaccine 11, 837-847.
17. [17] Li, C.J., Friedman, D.J., Wang, C., Metelev, V. and Pardee, A.B. (1995) Science 268, 429-431.
18. [18] Westendrop, M.O., Frank, R., Ochsenbauer, C., Stricker, K., Dhein, J., Walczak, H., Debatin, K.-M. and Krammer, P.H. (1995) Nature 375, 497-500.
19. [19] Otake, K., Fujii, Y., Nakaya, T, Nishino, Y., Zhong, Q., Fujinaga, K., Kameoka, M., Ohki, K. and Ikuta, K. (1994) J. Immunol. 153, 5826-5837.
20. [20] Fujii, Y., Nishino, Y., Nakaya, T., Tokunaga, K. and Ikuta, K. (1993) Vaccine 11, 1240-1246.